Citi analyst Hidemaru Yamaguchi downgraded SanBio to Neutral from Buy with a price target of 500 yen, down from 1,800 yen. The analyst thinks resolving the SB623 manufacturing issue will take time.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>